RecruitingEarly Phase 1NCT05597098

Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women

Studying Multiple endocrine neoplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Queen Mary University of London
Principal Investigator
Amrita Ahluwalia, BSc PhD
Queen Mary University of London
Intervention
Cantharidin(drug)
Enrollment
34 enrolled
Eligibility
18-45 years · All sexes
Timeline
20222027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05597098 on ClinicalTrials.gov

Other trials for Multiple endocrine neoplasia

Additional recruiting or active studies for the same condition.

See all trials for Multiple endocrine neoplasia

← Back to all trials